Determinants of functional, peak and endurance exercise capacity in people with chronic obstructive pulmonary disease

Respiratory Medicine

Volumn 138, Issue , 2018, Pages 81-87

  McNamara, Renae J ^a,b   Houben Wilke, Sarah ^a   Franssen, Frits M E ^a   Smid, Dionne E ^a   Vanfleteren, Lowie E G W ^a   Groenen, Miriam T J ^a   Uszko Lencer, Nicole H M K ^a   Wouters, Emiel F M ^a,c   Alison, Jennifer A ^d   Spruit, Martijn A ^a,c  

^a CIRO   (Netherlands)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cardiac; Chronic obstructive pulmonary disease; Determinants; Echocardiography; Exercise capacity; Lung function

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; BODY PLETHYSMOGRAPHY; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOCARDIOGRAPHY; ENDURANCE TRAINING; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTIONAL EXERCISE; HEART FUNCTION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PEAK EXERCISE; PRIORITY JOURNAL; SIX MINUTE WALK TEST; WORKLOAD; AGED; COMPLICATION; CROSS-SECTIONAL STUDY; DIAGNOSTIC IMAGING; DOPPLER ECHOCARDIOGRAPHY; EXERCISE TEST; EXERCISE TOLERANCE; HEART DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; VITAL CAPACITY;

AGED; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MUSCLES; SEVERITY OF ILLNESS INDEX; VITAL CAPACITY;

EID: 85044864000     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2018.03.032     Document Type: Article

References (46)

1. Spruit, M.A., Pennings, H.-J., Janssen, P.P., et al. Extra-pulmonary features in COPD patients entering rehabilitation after stratification for MRC dyspnea grade. Respir. Med. 101 (2007), 2454–2463.
2. Peruzza, S., Sergi, G., Vianello, A., et al. Chronic obstructive pulmonary disease (COPD) in elderly subjects: impact on functional status and quality of life. Respir. Med. 97 (2003), 612–617.
3. Oga, T., Nishimura, K., Tsukino, M., Sato, S., Hajiro, T., Analysis of the factors related to mortality in chronic obstructive pulmonary disease. Am. J. Resp. Crit Care 167:4 (2003), 544–549.
4. Dillard, T.A., Piantadosi, S., Rajagopal, K.R., Determinants of maximum exercise capacity in patients with chronic airflow obstruction. Chest 96 (1989), 267–271.
5. Wijkstra, P.J., TenVergert, E.M., van der Mark, T.W., et al. Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease. Thorax 49 (1994), 468–472.
6. Gosselink, R., Troosters, T., Decramer, M., Peripheral muscle weakness contributes to exercise limitation in COPD. Am. J. Resp. Crit. Care 153 (1996), 976–980.
7. Foglio, K., Carone, M., Pagani, M., Bianchi, P.L., Jones, P.W., Ambrosino, N., Physiological and symptom determinants of exercise performance in patients with chronic airway obstruction. Respir. Med. 94 (2000), 256–263.
8. Holland, A.E., Spruit, M.A., Troosters, T., et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur. Respir. J. 44 (2014), 1428–1446.
9. ATS/ACCP, ATS/ACCP statement on cardiopulmonary exercise testing. Am. J. Resp. Crit. Care 167:2 (2003), 211–277.
10. Donner, C., Goldstein, R., Ambrosino, N., Pulmonary Rehabilitation. 2005, CRC Press.
11. Vestbo, J., Hurd, S.S., Agusti, A.G., Rodriguez-Roisin, R., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am. J. Resp. Crit. Care 187:4 (2013), 347–365.
12. Hawkins, N.M., Petrie, M.C., Jhund, P.S., Chalmers, G.W., Dunn, F.G., McMurray, J.J.V., Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur. J. Heart Fail. 11:2 (2009), 130–139.
13. McGarvey, L.P., John, M., Anderson, J.A., Zvarich, M., Wise, R.A., TORCH clinical endpoint committee. Ascertainment of cause-specific mortality in COPD: operations of the TORCH clinical endpoint committee. Thorax 62:5 (2007), 411–415.
14. Divo, M., Cote, C., de Torres, J.P., et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am. J. Resp. Crit. Care 186:2 (2012), 155–161.
15. Laveneziana, P., Wadell, K., Webb, K., O'Donnell, D.E., Exercise limitation in chronic obstructive pulmonary disease. Curr. Respir. Med. Rev. 4 (2008), 258–269.
16. Chaouat, A., Naeije, R., Weitzenblum, E., Pulmonary hypertension in COPD. Eur. Respir. J. 32 (2008), 1371–1385.
17. Mesquita, R., Wilke, S., Smid, D.E., et al. Measurement properties of the Timed up & Go test in patients with COPD. Chron. Respir. Dis. 13:4 (2016), 344–352.
18. Mahler, D.A., Brent, B.N., Loke, J., Zaret, B.L., Matthay, R.A., Right ventricular performance and central hemodynamics during upright exercise in patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 130:5 (1984), 722–729.
19. Watz, H., Waschki, B., Boehme, C., Claussen, M., Meyer, T., Magnussen, H., Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity. Am. J. Resp. Crit. Care 177 (2008), 743–751.
20. Faludi, R., Hajdu, M., Vertes, V., et al. Diastolic dysfunction is a contributing factor to exercise intolerance in COPD. COPD 13:3 (2016), 345–351.
21. Cuttica, M.J., Shah, S.J., Rosenberg, S.R., et al. Right heart structural changes are independently associated with exercise capacity in non-severe COPD. PLoS One, 6(12), 2011, e29069, 10.137/journal.pone.0029069.
22. Lopez-Sanchez, M., Munoz-Esquerre, M., Huertas, D., et al. High prevalencd of left ventricle diastolic dysfunction in severe COPD associated with a low exercise capacity: a cross-sectional study. PLoS One, 8(6), 2013, e68034, 10.1371/journal.pone.0068034.
23. Smid, D.E., Wilke, S., Jones, P.W., et al. Impact of cardiovascular comorbidities on COPD Assessment Tests (CAT) and its responsiveness to pulmonary rehabilitation in patients with moderate to very severe COPD: protocol of the Chance study. BMJ Open, 5, 2015, e007536, 10.1136/bmjopen-2014-007536.
24. Houben-Wilke, S., Spruit, M.A., Uszko-Lencer, N.H.M.K., et al. Echocardiographic abnormalities and their impact on health status in patients with COPD referred for pulmonary rehabilitation. Respirology 22:5 (2017), 928–934.
25. Mesquita, R., Franssen, F.M., Houben-Wilke, S., et al. What is the impact of impaired left ventricular ejection fraction in COPD after adjusting for confounders?. Int. J. Cardiol. 225 (2016), 365–370.
26. Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chron. Dis. 40:5 (1987), 373–383.
27. Ponikowski, P., Voors, A.A., Anker, S.D., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J., 2016, 2016, 10.1093/eurheart/ehw128.
28. ATS/ERS, ATS/ERS statement on respiratory muscle testing. Am. J. Resp. Crit. Care 166 (2002), 518–624.
29. ATS/ERS, Standardisation of spirometry. Eur. Respir. J. 26 (2005), 319–338.
30. ATS/ERS, Standardisation of the measurement of lung volumes. Eur. Respir. J. 26 (2005), 511–522.
31. ATS/ERS, Standardisation of the single-breath determination of carbon monoxide uptake. Eur. Respir. J. 26 (2005), 720–735.
32. van't Hul, A., Gosselink, R., Kwakkel, G., Constant-load cycle endurance performance: test-retest reliability and validity in patients with COPD. J. Cardiopulm. Rehabil. 23:2 (2003), 143–150.
33. Taylor, N.A., Sanders, R.H., Howick, E.I., Stanley, S.N., Static and dynamic assessment of the Biodex dynamometer. Eur. J. Appl. Physiol. 62:3 (1991), 180–188.
34. Mathur, S., Makrides, L., Hernandez, P., Test-retest reliability of isometric and isokinetic torque in patients with chronic obstructive pulmonary disease. Physioth. Can 56 (2004), 94–101.
35. Mesquita, R., Janssen, D.J., Wouters, E.F., Schols, J.M., Pitta, F., Spruit, M.A., Within-day test-retest reliability of the Timed up & Go test in patients with advanced chronic organ failure. Arch. Phys. Med. Rehabil. 94:11 (2013), 2131–2138.
36. Jones, P.W., Harding, G., Berry, P., Wiklund, I., Chen, W.-H., Kline Leidy, N.K., Development and first validation of the COPD assessment test. Eur. Respir. J. 34 (2009), 648–654.
37. Meguro, M., Barley, E.A., Spencer, S., Jones, P.W., Development and validation of an improved, COPD-specific version of the St. George respiratory Questionnaire. Chest 132:2 (2007), 456–463.
38. Zigmond, A.S., Snaith, R.P., The hospital anxiety and depression scale. Acta Psychiatr. Scand., 67, 1983 361–37.
39. Field, A., Discovering Statistics Using SPSS. third ed., 2009, SAGE Publications Ltd, London ISBN 978-1-84787-906-6.
40. Oga, T., Nishimura, K., Tsukino, M., Hajiro, T., Ikeda, A., Mishima, M., Relationship between different indices of exercise capacity and clinical measures in patients with chronic obstructive pulmonary disease. Heart Lung 31:5 (2002), 374–381.
41. Andrianopoulos, V., Wagers, S.S., Groenen, M.T.J., et al. Characteristics and determinants of endurance cycle ergometry and six-minute walk distance in patients with COPD. BMC Pulm. Med., 14, 2014, 97, 10.1186/1471-2466-14-97.
42. Rodriguez, D.A., Garcia-Aymerich, J., Valera, J.L., et al. Determinants of exercise capacity in obese and non-obese COPD patients. Respir. Med. 108 (2014), 745–751.
43. Schoos, M.M., Dalsgaard, M., Kjaergaard, J., et al. Echocardiographic predictors of exercise capacity and mortality in chronic obstructive pulmonary disease. BMC Cardiovasc. Disord., 13, 2013, 84, 10.1186/1471-2261-13-84.
44. Ozdemirel, T.S., Ulash, S.S., Yetis, B., Karacaglar, E., Bayraktar, N., Ulubay, G., Effects of right ventricular dysfunction on exercise capacity and quality of life and associations with serum NT-proBNP levels in COPD: an observational study. Anadolu Kardiyol. Derg. 14 (2014), 370–377.
45. Anderson, C.U., Mellemkjaer, S., Nielsen-Kudsk, J.E., et al. Echocardiographic screening for pulmonary hypertension in stable COPD out-patients and NT-proBNP as a rule-out test. COPD 9:5 (2012), 505–512.
46. Calverley, P.M., Dynamic hyperinflation: is it worth measuring?. Proc. Am. Thorac. Soc. 3:3 (2006), 239–244.